Innovent Biologics Technology Limited (shanghai R&d Center)

This was an early, first-in-human study to check the safety and basic effects of a single dose of a new drug called IBI3032. It involved 40 healthy volunteers and tested how the body processes the drug, including whether taking it with or without food makes a difference. The main…